Copyright
©The Author(s) 2023.
World J Cardiol. Sep 26, 2023; 15(9): 427-438
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Table 1 Descriptive statistics of continuous variables
n | Minimum | Maximum | Mean | SD | |
Length of stay | 1788 | 1 | 117 | 11.77 | 11.73 |
Age | 1788 | 20 | 110 | 66.36 | 16.36 |
Body mass index | 1741 | 14.14 | 83.12 | 30.07 | 8.69 |
C-reactive protein | 1575 | 0.05 | 54.38 | 14.60 | 9.57 |
Lactate dehydrogenase | 1384 | 55 | 8180 | 487.45 | 525.15 |
Ferritin | 1240 | 5.1 | 47560.8 | 1038.56 | 2187.49 |
Troponin | 1788 | 0.01 | 32.78 | 0.49 | 2.41 |
Creatine phosphokinase | 979 | 10 | 88961 | 755.30 | 4495.43 |
Platelet | 1786 | 37 | 1176 | 328.47 | 138.68 |
White blood cell count | 1787 | 2.4 | 80.7 | 16.12 | 9.05 |
Potassium | 1513 | 2.70 | 8.50 | 4.82 | 0.84 |
Total bilirubin | 1780 | 0.2 | 27.8 | 1.01 | 1.16 |
Table 2 Descriptive analysis of categorical variable
Frequency | Percent | |
Gender | ||
Female | 749 | 41.9% |
Male | 1039 | 58.1% |
Race | ||
Asian | 109 | 6.1% |
Black | 81 | 4.5% |
White | 1152 | 64.4% |
Others | 446 | 24.9% |
Expired | ||
No | 1254 | 70.1% |
Yes | 534 | 29.9% |
Ventilator use | ||
No | 1352 | 75.6% |
Yes | 436 | 24.4% |
Intensive care unit | ||
No | 1328 | 74.3% |
Yes | 460 | 25.7% |
Remdesivir | ||
No | 853 | 49.1% |
Yes | 883 | 50.9% |
Dexamethasone | ||
No | 568 | 31.8% |
Yes | 1220 | 68.2% |
Angiotensin converting enzyme inhibitor | ||
No | 1441 | 80.6% |
Yes | 347 | 19.4% |
Diabetes mellitus | ||
No | 1444 | 80.8% |
Yes | 344 | 19.2% |
Hypertension | ||
No | 1032 | 57.7% |
Yes | 756 | 42.3% |
Chronic kidney disease | ||
No | 1355 | 76.0% |
Yes | 427 | 24.0% |
Acute kidney injury | ||
No | 1588 | 88.8% |
Yes | 200 | 11.2% |
Congestive heart failure | ||
No | 1451 | 81.2% |
Yes | 337 | 18.8% |
Chronic obstructive pulmonary disease | ||
No | 1678 | 93.8% |
Yes | 110 | 6.2% |
Bradycardia | ||
No | 823 | 46.0% |
Yes | 965 | 54.0% |
Troponin elevation | ||
No | 1583 | 88.5% |
Yes | 205 | 11.5% |
Table 3 Bivariate analysis of the relationship between continuous variables and troponin elevation
Troponin elevation | n | Mean | SD | P value | |
Length of stay | 0 | 1583 | 11.46 | 11.44 | 0.007 |
1 | 205 | 14.16 | 13.52 | ||
Age | 0 | 1583 | 66.14 | 16.49 | 0.08 |
1 | 205 | 68.13 | 15.29 | ||
Body mass index | 0 | 1540 | 30.11 | 8.62 | 0.64 |
1 | 201 | 29.80 | 9.20 | ||
Oxygen on admission | 0 | 1415 | 94.47 | 6.27 | 0.27 |
1 | 187 | 94.20 | 6.69 | ||
C-reactive protein | 0 | 1393 | 14.23 | 9.50 | < 0.001 |
1 | 182 | 17.47 | 9.70 | ||
Lactate dehydrogenase | 0 | 1236 | 447.71 | 363.69 | < 0.001 |
1 | 148 | 819.34 | 1165.85 | ||
Ferritin | 0 | 1099 | 956.44 | 1859.08 | 0.03 |
1 | 141 | 1678.58 | 3844.02 | ||
Creatine phosphokinase | 0 | 863 | 586.10 | 4245.13 | 0.01 |
1 | 116 | 2014.03 | 5913.58 | ||
Platelet | 0 | 1582 | 331.24 | 138.55 | 0.02 |
1 | 204 | 307.00 | 138.15 | ||
WBC | 0 | 1583 | 15.66 | 8.97 | < 0.001 |
1 | 204 | 19.76 | 8.88 | ||
Potassium | 0 | 1341 | 4.78 | 0.83 | < 0.001 |
1 | 172 | 5.07 | 0.92 | ||
Total bilirubin | 0 | 1577 | 0.95 | 0.83 | 0.004 |
1 | 203 | 1.46 | 2.48 |
Table 4 Bivariate analysis of the relationship between categorical variables and troponin elevation
Variable | Troponin elevation | P value | |
No | Yes | ||
Gender | |||
Male | 918 (88.4%) | 121 (11.6%) | 0.78 |
Female | 665 (88.8%) | 84 (11.2%) | |
Race | |||
Asia | 96 (88.1%) | 13 (11.9%) | 0.38 |
Black | 72 (88.9%) | 9 (11.1%) | |
White | 1030 (89.4%) | 122 (10.6%) | |
Others | 385 (86.3%) | 61 (13.7%) | |
Expired | |||
Yes | 415 (77.7%) | 119 (22.3%) | < 0.001 |
No | 1168 (93.1%) | 86 (6.9%) | |
Ventilator | |||
Yes | 334 (76.6%) | 102 (23.4%) | < 0.001 |
No | 1249 (92.4%) | 103 (7.5%) | |
Intensive care unit | |||
Yes | 354 (77.0%) | 106 (23.0%) | < 0.001 |
No | 1229 (92.5%) | 99 (7.5%) | |
Diabetes mellitus | |||
Yes | 314 (91.3%) | 30 (8.7%) | 0.08 |
No | 1269 (87.9%) | 175 (12.1%) | |
Hypertension | |||
Yes | 677 (89.6%) | 79 (10.4%) | 0.25 |
No | 906 (87.8%) | 126 (12.2%) | |
Chronic kidney disease | |||
Yes | 354 (82.9%) | 73 (17.1%) | <0.001 |
No | 1223 (90.3%) | 132 (9.7%) | |
Congestive heart failure | |||
Yes | 279 (82.8%) | 58 (17.2%) | < 0.001 |
No | 1304 (89.9%) | 147 (10.1%) | |
Chronic obstructive pulmonary disease | |||
Yes | 96 (87.3%) | 14 (12.7%) | 0.67 |
No | 1487 (88.6%) | 191 (11.4%) | |
Bradycardia | |||
Yes | 853 (88.4%) | 112 (11.6%) | 0.84 |
No | 730 (88.7%) | 93 (11.3%) | |
Use of Remdesivir | |||
Yes | 789 (89.4%) | 94 (10.6%) | 0.28 |
No | 748 (87.7%) | 94 (12.3%) | |
Use of dexamethasone | |||
Yes | 1069 (87.6%) | 151 (12.4%) | 0.08 |
No | 514 (90.5%) | 54 (9.5%) |
Table 5 Logistic regression on predictors of increased troponin elevation
B | SE | Wald | df | Sig | Exp (B) | 95%CI for EXP (B) | ||
Lower | Upper | |||||||
Lactate dehydrogenase | 0.000 | 0.000 | 8.091 | 1 | 0.004 | 1.000 | 1.000 | 1.001 |
Congestive heart failure | 0.991 | 0.239 | 17.170 | 1 | 0.000 | 2.694 | 1.686 | 4.305 |
Intensive care unit | 1.278 | 0.232 | 30.359 | 1 | 0.000 | 3.591 | 2.279 | 5.659 |
Constant | -3.154 | 0.194 | 264.436 | 1 | 0.000 | 0.043 |
Table 6 Cox regression analysis showing predictors of mortality in coronavirus disease 2019 patients
B | SE | Wald | df | Sig | Exp (B) | 95%CI for Exp (B) | ||
Lower | Upper | |||||||
Age | 0.022 | 0.004 | 26.460 | 1 | 0.000 | 1.022 | 1.014 | 1.031 |
Ventilator use | -0.378 | 0.157 | 5.830 | 1 | 0.016 | 0.685 | 0.504 | 0.931 |
Intensive care unit admission | 1.624 | 0.164 | 97.657 | 1 | 0.000 | 5.074 | 3.677 | 7.003 |
Troponin | 0.219 | 0.133 | 2.705 | 1 | 0.100 | 1.245 | 0.959 | 1.616 |
- Citation: Umeh CA, Maoz H, Obi J, Dakoria R, Patel S, Maity G, Barve P. Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation. World J Cardiol 2023; 15(9): 427-438
- URL: https://www.wjgnet.com/1949-8462/full/v15/i9/427.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i9.427